</s><s><s><s> vaccination against human papillomavirus ( hpv ) is a first - generation vaccine for the prevention and treatment of cervical cancer. 
 hpv is licensed in the united states for use in persons aged > 26 years, but it is not licensed for the use of persons aged 26 years. in this review, 
 recommendations and recommendations are provided for use of hpv in persons older than 26 years of age, including persons aged 9 to 15 years, persons on antiretroviral therapy, and persons aged 16 to 26 years who are infected with human immunodeficiency virus ( hiv ). </s>